Cargando…

CD154 Blockade Alters Innate Immune Cell Recruitment and Programs Alloreactive CD8(+) T Cells into KLRG-1(high) Short-Lived Effector T Cells

CD154/CD40 blockade combined with donor specific transfusion remains one of the most effective therapies in prolonging allograft survival. Despite this, the mechanisms by which these pathways synergize to prevent rejection are not completely understood. Utilizing a BALB/c (H2-K(d)) to B6 (H2-K(b)) f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrer, Ivana R., Wagener, Maylene E., Song, Mingqing, Ford, Mandy L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390379/ https://www.ncbi.nlm.nih.gov/pubmed/22792369 http://dx.doi.org/10.1371/journal.pone.0040559

Ejemplares similares

Selective CD28 blockade impacts T cell differentiation during homeostatic reconstitution following lymphodepletion
por: Habib, Jakob G., et al.
Publicado: (2023)

2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8(+) T cell responses
por: Liu, Danya, et al.
Publicado: (2014)

PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127(+) and KLRG1(+) CD8 T cells
por: Hui, Zhenzhen, et al.
Publicado: (2023)

CD28/CD154 Blockade Prevents Autoimmune Diabetes by Inducing Nondeletional Tolerance After Effector T-Cell Inhibition and Regulatory T-Cell Expansion
por: Rigby, Mark R., et al.
Publicado: (2008)

The Yin and Yang of Targeting KLRG1(+) Tregs and Effector Cells
por: Borys, Samantha M., et al.
Publicado: (2022)

Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens
por: Ashokkumar, Chethan, et al.
Publicado: (2015)

PD-1 regulates KLRG1(+) group 2 innate lymphoid cells
por: Taylor, Samuel, et al.
Publicado: (2017)

Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1(+)CD8 T cells
por: Wang, Chao, et al.
Publicado: (2019)

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation
por: Kalin, Burak, et al.
Publicado: (2020)

IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter
por: Lowe, RM, et al.
Publicado: (2014)

CD154-CD40 interactions in the control of murine B cell hematopoiesis
por: Carlring, Jennifer, et al.
Publicado: (2011)

Reduced Ebola vaccine responses in CMV(+) young adults is associated with expansion of CD57(+)KLRG1(+) T cells
por: Bowyer, Georgina, et al.
Publicado: (2020)

Ptpn2 and KLRG1 regulate the generation and function of tissue-resident memory CD8(+) T cells in skin
por: Hochheiser, Katharina, et al.
Publicado: (2021)

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response
por: Ager, Casey R, et al.
Publicado: (2023)

Chronic Alcohol Ingestion Delays T Cell Activation and Effector Function in Sepsis
por: Margoles, Lindsay M., et al.
Publicado: (2016)

KLRG1 and CD103 Expressions Define Distinct Intestinal Tissue-Resident Memory CD8 T Cell Subsets Modulated in Crohn's Disease
por: Bottois, Hugo, et al.
Publicado: (2020)

Polyfunctional KLRG-1(+)CD57(+) Senescent CD4(+) T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients
por: Ramello, Maria C., et al.
Publicado: (2021)

CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
por: Chauchet, Xavier, et al.
Publicado: (2022)

Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS
por: Goovaerts, Odin, et al.
Publicado: (2019)

CD154 blockade modulates the ratio of Treg to Th1 cells and prolongs the survival of allogeneic corneal grafts in mice
por: TAN, XIAOBO, et al.
Publicado: (2014)

Skin immunisation activates an innate lymphoid cell-monocyte axis regulating CD8(+) effector recruitment to mucosal tissues
por: Zaric, Marija, et al.
Publicado: (2019)

Expression of IL‐7Rα and KLRG1 defines functionally distinct CD8(+) T‐cell populations in humans
por: Remmerswaal, Ester B. M., et al.
Publicado: (2019)

Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis
por: Tung, Chien-Hsueh, et al.
Publicado: (2017)

TNF Blockade Maintains an IL-10(+) Phenotype in Human Effector CD4(+) and CD8(+) T Cells
por: Roberts, Ceri A., et al.
Publicado: (2017)

TL1A Increases Expression of CD25, LFA-1, CD134 and CD154, and Induces IL-22 and GM-CSF Production from Effector CD4 T-Cells
por: Reichwald, Kirsten, et al.
Publicado: (2014)

KLRG1 restricts memory T cell antitumor immunity
por: Li, Lei, et al.
Publicado: (2016)

Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation
por: Bengsch, Bertram, et al.
Publicado: (2010)

Inhibition of Donor-Reactive CD8+ T Cell Responses by Selective CD28 Blockade Is Independent of Reduced ICOS Expression
por: Liu, Danya, et al.
Publicado: (2015)

Activated CD4(+) T Cells and Highly Differentiated Alloreactive CD4(+) T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients
por: Duizendstra, Aafke A., et al.
Publicado: (2021)

New frontiers for platelet CD154
por: Dewitte, Antoine, et al.
Publicado: (2015)

CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival
por: Liu, Huazhen, et al.
Publicado: (2019)

CD4(+) T helper cells use CD154–CD40 interactions to counteract T reg cell–mediated suppression of CD8(+) T cell responses to influenza
por: Ballesteros-Tato, André, et al.
Publicado: (2013)

Expression of KLRG1 and CD127 defines distinct CD8(+) subsets that differentially impact patient outcome in follicular lymphoma
por: Wu, Hongyan, et al.
Publicado: (2021)

IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential “inflammatory” type 2 innate lymphoid cells
por: Huang, Yuefeng, et al.
Publicado: (2014)

GITR Activation Induces an Opposite Effect on Alloreactive CD4(+) and CD8(+) T Cells in Graft-Versus-Host Disease
por: Muriglan, Stephanie J., et al.
Publicado: (2004)

Delayed Anti-CD3 Therapy Results in Depletion of Alloreactive T Cells and the Dominance of Foxp3(+)CD4(+) Graft Infiltrating Cells
por: Goto, R, et al.
Publicado: (2013)

Persistent Polyclonal B Cell Lymphocytosis B Cells Can Be Activated through CD40-CD154 Interaction
por: Dugas-Bourdages, Emmanuelle, et al.
Publicado: (2014)

Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers
por: Tata, Angela, et al.
Publicado: (2021)

Effect of CD154-CD40 interactions on collagen production by fibroblasts
por: Yurovsky, VV, et al.
Publicado: (2001)

A Role for CD154, the CD40 Ligand, in Granulomatous Inflammation
por: Villeneuve, Julien, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bgvgvbhtl13urgsi204oq001uk